Physician profile

Jose Matos

Dentist · Clearwater, FL

NPI 1962590703

$1,206.92

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$510.39
Travel and Lodging$213.22
Honoraria$24.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sonendo INC $490.79 2023 Gentlewave G4 Console
Zimmer Biomet Holdings, INC. $389.72 2019-2021
Benco Dental Supply Co. $237.72 2023
Dentsply Sirona INC $33.24 2020
Nobel Biocare USA $19.60 2023 Nobelactive
Philips North America LLC $17.94 2021
Orapharma, A Division of Bausch Health US, LLC $17.91 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jose Matos

$1,206.92

in general payments reported 2019-2025

Years
2019-2023
Top company
Sonendo INC

https://glasscript.com/doctor/316372/jose-matos

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.